Why the study?
Is routine testing for aspirin resistance valid and clinically useful in patients on low-dose aspirin?
Is routine testing for aspirin resistance valid and clinically useful in patients on low-dose aspirin?
Answers are grounded in this paper and cite their sources.
Routine testing for aspirin resistance is not ready for clinical use due to the lack of standardized definitions and evidence-based treatment strategies for affected patients.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Paul Hjemdahl (2009) conducted an editorial in stable coronary artery disease (n=172). Aspirin (ASA) was evaluated on residual platelet activity.
Synapse has enriched 10 related papers. Consider them for comparative context: